Navigation Links
Catherine M. Burzik Elected as BD Director
Date:1/29/2013

FRANKLIN LAKES, N.J., Jan. 29, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that Catherine M. Burzik has been elected to its Board of Directors.

Ms. Burzik, 62, is a seasoned healthcare executive with leadership experience in medical device, diagnostic, diagnostic imaging and life sciences businesses. Most recently, from 2006 until the sale of the company in 2012, she served as President, Chief Executive Officer and Director of Kinetic Concepts, Inc., a medical device company specializing in woundcare and regenerative medicine. Her prior positions include service as President of Applied Biosystems, a leading DNA sequencing company, as well as senior positions at Eastman Kodak and Johnson & Johnson.

"I am pleased and honored to welcome Catherine Burzik to the BD Board," said Vincent A. Forlenza , BD Chairman, Chief Executive Officer and President. "Cathy has a strong and diversified background in several key sectors of the healthcare industry, as well as extensive knowledge of the global healthcare arena.  I know that she will make important strategic contributions to the Board as we evaluate the many opportunities BD has to continue innovating to improve healthcare around the world."

Ms. Burzik currently serves as Chair of the Board of Directors of VitaPath Genetics, Inc. and is a member of the San Antonio Branch of the Dallas Federal Reserve Board. She also serves as Chair, Canisius College Board of Trustees and is a member of the Board of Directors of ViroXis Corporation and the Board of Trustees of Keck Graduate School of Applied Life Sciences.

Ms. Burzik received a bachelor's degree in Mathematics from Canisius College and a masters' degree in Mathematics from the University of Buffalo.

About BD
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world.  BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contacts:
Colleen T. White , Corporate Communications – 201-847-5369;
 colleen_white@bd.com 
Monique N. Dolecki , Investor Relations – 201-847-5378;
 monique_dolecki@bd.com


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bench International Adds Catherine Balin to Executive Team
2. Catherine Sohn Elected To Jazz Pharmaceuticals Board Of Directors
3. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
4. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
5. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
6. DICOM Grid Selected as a Finalist for the 2012 Red Herring Top 100 Americas Award
7. Centene Corporation Selected for Ohio Medicaid Contract
8. Bench Internationals Denise (DeeDee) DeMan Elected to SoCalBios Board of Directors
9. Sterne, Kessler, Goldstein & Fox Selected by 15 Year Old Winner of Intel International Science and Engineering Fair
10. Nature Made Selected As "Top Recommended Health Product" By U.S. News & World Report And Pharmacy Times
11. ApolloMed ACO Selected To Participate In A Transformative New Initiative Sponsored by the Centers for Medicare and Medicaid Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
(Date:6/23/2016)... 23, 2016 The vast majority of dialysis ... facility.  Treatments are usually 3 times a week, with ... including travel time, equipment preparation and wait time.  This ... grueling for patients who are elderly and frail.  Many ... and rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
Breaking Medicine News(10 mins):